A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A)
- 1 January 1979
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 15 (3-4) , 373-388
- https://doi.org/10.1016/0049-3848(79)90145-2
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Sulfinpyrazone in the Prevention of Cardiac Death after Myocardial InfarctionNew England Journal of Medicine, 1978
- Aspirin Prophylaxis of Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1977
- Controlled trial of aspirin in cerebral ischemia.Stroke, 1977
- Clinical pharmacology of flurbiprofen: a novel inhibitor of platelet aggregationCurrent Medical Research and Opinion, 1977
- Aspirin in coronary heart diseaseJournal of Chronic Diseases, 1976
- The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosis.Circulation, 1975
- Studies of Platelet and Fibrinogen Kinetics in Patients with Prosthetic Heart ValvesNew England Journal of Medicine, 1970
- Effect of prostaglandin E1 on platelet aggregation in vitro and in hemorrhagic shockMicrovascular Research, 1969
- Screen filtration pressure method and adhesiveness and aggregation of blood cellsJournal of Applied Physiology, 1964
- Adhesiveness of platelets and leukocytes during acute exsanguinationAmerican Journal of Physiology-Legacy Content, 1962